|
TMEM14B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.93209999999456E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.660200E-02 |
| Stage1-vs-Stage3 |
4.428500E-02 |
| Stage1-vs-Stage4 |
1.32370000516246E-08 |
| Stage2-vs-Stage3 |
7.518600E-03 |
| Stage2-vs-Stage4 |
2.09139999999275E-05 |
| Stage3-vs-Stage4 |
3.115700E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.65621999999033E-05 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
8.889600E-01 |
| Caucasian-vs-Asian |
2.017200E-01 |
| AfricanAmerican-vs-Asian |
5.299400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.888600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64435132177232E-12 |
| Normal-vs-Age(81-100Yrs) |
7.949800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.054400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.911400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.569000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.639600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.187000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.801400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.247800E-04 |
| Classical-VS-Follicular |
8.2558999969784E-08 |
| Classical-VS-Other |
3.494400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.47709622311254E-11 |
| Tall-VS-Other |
1.368840E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.087000E-01 |
| Follicular-VS-Normal |
1.558940E-04 |
| Other-VS-Normal |
5.159200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.32827124036339E-15 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.29400000054214E-07 |
|
|
